RCN Qualification — Commercialisation of Research
Funds feasibility studies that convert publicly funded Norwegian research into commercial products and services.
The RCN Qualification grant is the Research Council of Norway's entry-level instrument for commercialising publicly funded research, providing NOK 100,000 to NOK 500,000 for projects lasting 3 to 12 months. The 2026 programme pool is NOK 60 million, distributed on a rolling intake basis with no fixed annual deadline. The grant is designed to bridge the gap between a research result and a viable co…
Commercially promising technologies originating from publicly funded Norwegian research organisations, TTOs, or early-stage spin-outs.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
BudgetGrant Budget Template for R&D Applications
Use this grant budget template to structure R&D costs, personnel, subcontractors, equipment, indirect costs, and budget justification for startup grant applications.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
More from RCN
All grants from this funder →RCN Innovation Project: Agriculture and Food (FFL/JA)
🇳🇴RCN · Norway
Funds Norwegian agriculture and food companies carrying out industrial research or experimental development through RCN innovation grants.
SkatteFUNN — R&D Tax Deduction
🇳🇴RCN · Norway
Provides Norwegian companies with tax based SkatteFUNN support for qualified technology spending and innovation process costs.
SFF VI — Norwegian Centres of Excellence Phase 2
🇳🇴RCN · Norway
Funds world-class Norwegian research centres through a flagship support mechanism with broad excellence focus.
FRIPRO — Radical Research Ideas (Early Career Scientists)
🇳🇴RCN · Norway
Funds early-career Norwegian researchers exploring radical ideas through short high-risk experimental grants.
FRIPRO — Researcher Project for Early Career Scientists
🇳🇴RCN · Norway
Funds early-career Norwegian scientists through in-depth development opportunities at national research organisations.
FRIPRO — Researcher Project for Experienced Scientists
🇳🇴RCN · Norway
Funds experienced Norwegian researchers with flagship support for broad, high-impact research and collaboration.
Similar grants
Browse the directory →
Start-up Grant Phase 1 — Market Clarification
🇳🇴Innovation Norway · Norway
Funds young Norwegian start-ups validating market need and business feasibility in their early growth journey.
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.
Young Cancer Survivors Quality of Life Network
🇪🇺European Commission · European Union
Funds one €3M coordination action that helps cancer charities and funders improve quality of life for young survivors across Europe.
Personalised approaches to reduce risks from adverse drug reactions due to multiple medications
🇪🇺European Commission · European Union
Funds safer medication management using biomarkers, clinical data and decision support.
Innovation Norway Innovation Contracts Grant (Innovasjonskontrakter)
🇳🇴Innovation Norway · Norway
Supports Norwegian innovators and customers through co-developed solutions with market focus.
Cancer Mission: First-in-Human Trials for Rare Cancers
🇪🇺European Commission · European Union
Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.